Target
HER4
2 abstracts
Abstract
Pyrotinib in HER2-altered advanced salivary gland carcinomas: Analysis of two cohorts from an exploratory study.Org: Department of Oral and Maxillofacial Head & Neck Oncology, Shanghai Ninth People’s Hospital,
Abstract
Pyrotinib maleate for the treatment of brain metastases from HER2-positive solid tumours: A real-world study.Org: Beijing Tian Tan Hospital, Capital Medical University, Capital Medical University, Beijing InnoCare Pharma Tech,